TODD STRATEGY GROUP

Lobbying for GENMAB · Biotech company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2025 · New Jersey · House · Senate · $60,000.00 income · posted Jul 19, 2025

Lobbying activity 2

Health Issues

Prescription Drug Pricing. Implementation of Inflation Reduction Act of 2022.

Medicare/Medicaid

General Medicare/Medicaid Issues. 340B Issues.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.